Embark Biotech
Copenhagen · Founded 2017
About Embark Biotech
Embark Biotech is an early-stage biotech company that identifies novel cell surface receptors that physiologically regulate fat tissue calorie-burning and glucose and lipid uptake. The company was founded in 2017 and is headquartered in Copenhagen, Denmark.
Company Facts
- Founded: 2017
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.6M
- Funding stage: M&A
- Last round: Convertible Note (Sep 2021)
- Website: https://embarkbiotech.com/
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/embark-biotech-123519 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.